Andere talen Azitra, Inc.

Aandelen

AZTR

US05479L1044

Geschatte realtime Cboe BZX Andere beurzen 18:45:36 13-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,195 ^USD	-9,72%		-25,09%	-78,33%

10/05	Azitra, Inc. Kondigt positieve preklinische gegevens van ATR-12 en klinisch ontwerp voor het Netherton-syndroom aan, gepresenteerd op de jaarlijkse ASGCT-bijeenkomst	CI
09/05	Azitra, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	17:22
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	09/05
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22/04
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	18/04
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	15/03
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Azitra Closes $5 Million Public Offering	16/02
Azitra, Inc. Announces Closing of Public Offering	16/02
Top Midday Decliners	14/02
Azitra Prices Stock Offering at $0.30 a Share	14/02
Azitra, Inc. Announces Pricing of Public Offering	14/02
Azitra Launches Common Stock Offering; Shares Drop	19/01
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US	16/01
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference	03/01
Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-DEC-2023.	16/12
Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-DEC-2023.	16/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Azitra, Inc.

Aandelen

AZTR

US05479L1044

Andere talen

Filters